Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.47 |
| ▸ | SCN4A | P35499 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | CASP3 | P42574 | 2/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28326433 | 0.93 | ACHE (0.52) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL19664327 | 0.93 | SCN2A (0.50) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL20392617 | 0.93 | SCN2A (0.50) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL2786777 | 0.88 | MAPT (0.43) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL28326393 | 0.87 | RAB9A (0.42) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL14013397 | 0.82 | KDM4E (0.49) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL25374033 | 0.82 | HSP90AA1 (0.42) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL186791 | 0.79 | RAB9A (0.44) | KDM4EMAPTTHRBPKMTDP1 | |
| SCHEMBL7212912 | 0.78 | DYRK1A (0.47) | KDM4EMAPTTDP1NPC1RAB9A | |
| SCHEMBL28327646 | 0.78 | KDM4E (0.45) | KDM4EMAPTTHRBPKMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115141220-B | Aza-BODIPY compound and application thereof in nanoparticle in-vivo tracking | 复旦大学 | 2025-03-11 | — | — | CN | claimed |
| CN-115141220-A | Aza-BODIPY compound and application thereof in-vivo tracing of nanoparticles | 复旦大学 | 2022-10-04 | — | — | CN | claimed |
| CN-115141220-B | Aza-BODIPY compound and application thereof in nanoparticle in-vivo tracking | 复旦大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-115141220-A | Aza-BODIPY compound and application thereof in-vivo tracing of nanoparticles | 复旦大学 | 2022-10-04 | — | — | CN | disclosed |
| CN-110283159-B | 2, 4-disubstituted pyrrole or 2,3, 4-trisubstituted pyrrole prepared by one-pot method and preparation method thereof | 河南大学 | 2020-09-29 | — | — | CN | disclosed |
| CN-110283159-A | Tri- substituted azole of 2,3- disubstituted pyrroles or 2,3,4- and preparation method thereof of one kettle way preparation | 河南大学 | 2019-09-27 | — | — | CN | disclosed |
| EP-1253151-B1 | Pyrromethene metal complex and light emitting device composition and light emitting devices using the same | TORAY INDUSTRIES (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6805978-B2 | COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND | TORAY INDUSTRIES, INC. (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20030082406-A1 | Complex containing diketopyrrolo(3,4-c)pyrrole compound | TORAY INDUSTRIES, INC. (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1253151-A1 | Pyrromethene metal complex and light emitting device composition and light emitting devices using the same | TORAY INDUSTRIES, INC. (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082406-A1 | Complex containing diketopyrrolo(3,4-c)pyrrole compound | PPOX, CPNE4, TP53RK | KDM4E 633/4885MAPT 1969/4885THRB 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.